Phil Smith's Guide to Building the Crow's Nest Mercury Spacecraft
Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years...
12
Transcript of Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years...
![Page 1: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/1.jpg)
![Page 2: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/2.jpg)
![Page 3: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/3.jpg)
![Page 4: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/4.jpg)
![Page 5: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/5.jpg)
![Page 6: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/6.jpg)
![Page 7: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/7.jpg)
![Page 8: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/8.jpg)
![Page 9: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/9.jpg)
![Page 10: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/10.jpg)
![Page 11: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/11.jpg)
![Page 12: Photon Groupstatic.photongroup.com/pdf/efficacy-oxinova.pdf · 05-01-2009 · female (Ž 35 years of age, visible crow's feet) clinically healthy for exclusion from study: skin diseases](https://reader033.fdocuments.us/reader033/viewer/2022050219/5f655a16c65e454638016938/html5/thumbnails/12.jpg)